Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.